Welcome to the Children & Screens Study!
Thank you for your interest in participating in this study.
EurekaFacts, a Maryland-based research company, is administering an important study on behalf of Children and Screens: Institute of Digital Media and Child Development.
We are recruiting healthcare providers and mental health professionals with experience treating children, adolescents, and/or families to participate in focus group sessions where they will discuss their professional experiences with digital media and screen use in children as well as the type of tools, information, and resources they already use and/or would need to effectively assess and address screen use-related health concerns in a clinical setting.
The ultimate goal is to provide the Media Impact Screening Toolkit workgroup that Children and Screens sponsors with information that will help develop a toolkit to be used by medical or mental health professionals like yourself to identify and address conditions related to screen use in pediatric populations.
The session will last approximately 2 hours. Although the session may be video recorded, your responses will be anonymized and won’t be shared in any identifiable format. Your responses would only be used for the purposes of this research and would never be shared with your place of work.
If you qualify and participate in the study, you will be compensated with a $150 gift card from a major credit card company as a ‘thank you’ for your time, effort, and feedback.
For more information about the study, please see the Frequently Asked Questions (FAQs) below. Alternatively, please call Cecilia Teal at 240-403-4800 x264 or e-mail firstname.lastname@example.org with any questions regarding this project.
If you are interested in participating, please click on the following link and answer a few screener questions.
What is this study about?
On behalf of Children and Screens: Institute of Digital Media and Child Development and the Media Impact Screening Toolkit (MIST) workgroup they sponsor, EurekaFacts, a research company based in Rockville, MD, is administering focus groups with health care providers and mental health professionals in various parts of the country. Participants will be asked to discuss their professional experiences with digital media and screen use in children and to consider the types of tools, information, and resources they would need to effectively assess and treat screen-related health concerns. This information will enable the MIST Toolkit to be developed, validated, and distributed.
What is Children and Screens: Institute of Digital Media and Child Development?
Children and Screens is one of the world’s preeminent research centers for advancing the latest interdisciplinary scientific research regarding digital media use, and educating the public with information and advice, enhancing talent in the field, and advocating for sound public policy. For more information visit ChildrenAndScreens.com.
What is the Media Impact Screening Toolkit (MIST) Workgroup?
Children and Screens launched an international workgroup of leading interdisciplinary researchers to develop an innovative a suite of instruments for use in clinical settings and to help inform clinical practice and decision making in a variety of contexts. The workgroup is led under the stewardship of distinguished medical and scientific advisors (see list on this page).
Where will the focus group session take place?
The focus groups will be held in Rockville, MD, San Diego, CA, and Chicago, IL. The specific testing site address will be provided to interested participants. Virtual participation is available based on participant eligibility.
What will happen during the focus group?
During the focus group, participants will discuss their impressions of digital media and screen use as it pertains to their professional experience treating young patients. A EurekaFacts moderator will be present to pose questions meant to guide the topics of discussion. Each session will be video-recorded.
Will information be kept private?
Each participant will be assigned a unique identifier (ID), and their name will not be linked to their answers. All of the information provided by participants may be used only for statistical purposes and may not be disclosed, or used, in identifiable form for any other purpose except as required by law (20 U.S.C. §9573 and 6 U.S.C. §151). Audio and any video from the session will be recorded only for analysis.
How long will the focus group last?
The focus group will be completed in one session and will last no more than 120 minutes.
Will the results be shared with the participant’s place of work?
Participants’ responses will not be disclosed to their place of work and will not be linked to any personally identifiable information.
Is there an incentive for participating?
Participants who participate in person will receive a $150 gift card from a major credit card company as a thank you for their time, effort, and expert testimony. Those who participate virtually will receive a $150 e-gift card from a major credit card company via email. Participants can expect their e-gift card within 5-10 business days of the completion of the remote focus group.
What are the possible risks of being in the study?
There are no known risks to participating in this voluntary study.
Can participation end early?
Participation in this study is completely voluntary. The participant has the right to refuse to answer particular questions. The participant may elect to withdraw from this study at any time and can leave the focus group early if they wish.
Who can I contact with questions or for further information?
Media Impact Screening Toolkit Membership
|Tracy Asamoah, MD, private practice, Texas|
|Julie Balaban, MD, Dartmouth Geisel School of Medicine|
|Rachel F. Barr, PhD, Georgetown University|
|Courtney K. Blackwell, PhD, Northwestern University, Feinberg School of Medicine|
|Florence Breslin, PhD, Laureate Institute for Brain Research|
|Joanne Broder, PhD, Saint Joseph’s University, Co-Founding Editor, Psychology of Popular Media Culture|
|Dillon Browne, PhD, University of Waterloo|
|Nicholas Carson, MD, FRCPC, Cambridge Health Alliance, Harvard Medical School|
|Dimitri A. Christakis, MD, MPH, Editor-in-Chief, JAMA Pediatrics, Seattle Children’s Research Institute|
|Christoph U. Correll, MD, Hofstra Northwell School of Medicine, Feinstein Institute for Medical Research, The Zucker Hillside Hospital|
|Katherine Cost, PhD, The Hospital for Sick Children|
|Katia Delrahim Howlett, PhD, MPP, MBA, National Institutes of Health|
|Zsolt Demetrovics, PhD, ELTE Eötvös Loránd University, Editor-in-Chief of Journal of Behavioral Addictions|
|Jennifer Emond, PhD, Dartmouth Geisel School of Medicine|
|Bernard F. Fuemmeler PhD, MPH, Virginia Commonwealth University|
|Richard C. Gershon, PhD, Northwestern University, Feinberg School of Medicine|
|Lauren Hale, PhD, Stony Brook Medicine; Editor, Sleep Health Journal|
|John S. Hutton, MS, MD, FAAP, Cincinnati Children’s Hospital|
|Diane J. Kim, PhD, Stony Brook University|
|Heather Kirkorian, PhD, University of Wisconsin-Madison|
|Monique LeBourgeois, PhD, University of Colorado, Boulder|
|Sheri Madigan, PhD, R.Psych, University of Calgary|
|Jessica Mendoza, University of Alabama|
|Ross D. Neville, PhD, University College Dublin|
|Martin Paulus, MD, Laureate Institute for Brain Research|
|Greg Perlman, PhD, Stony Brook University|
|Thomas Robinson, MD, MPH, Children’s Hospital at Stanford|
|Heather Prime, PhD, C. Psych., McMaster University|
|Hans-Jüergen Rumpf, PhD, University of Lübeck|
|Tim J. Smith, PhD, Birkbeck, University of London|
|Darcy Thompson, M.D., M.P.H./M.S.P.H., Children’s Hospital Denver|
|Stephen Uzzo, PhD, New York Hall of Science/NYIT|
|Paul Weigle, MD, Natchaug Hospital|